Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Volume 36 - Issue 5 - May, 2024

Featured Article

Original Contribution
A Comparison Between Radial Artery Compression Devices for Patent Hemostasis After Transradial Percutaneous Interventions
02/26/2024

Luigi Di Serafino, MD, PhD1; Maurizio Turturo, MD2; Claudio Larosa, MD3; Maria Scalamogna, MD1; Plinio Cirillo, MD, PhD1; Vito Alessandro Angelilli2; Saverio Lanzone, MD2; Francesco Bartolomucci, MD, PhD3; Riccardo Granata, MD1; Francesco Saverio Rea, MD1; Raffaele Piccolo, MD, PhD1; Anna Franzone, MD, PhD1; Giuseppe Gargiulo, MD, PhD1; Carmen Anna Maria Spaccarotella, MD, PhD1; Eugenio Stabile,MD, PhD1,4; Giovanni Esposito, MD, PhD1

Luigi Di Serafino, MD, PhD1; Maurizio...
This study evaluated whether the use of an adjustable device inflated with a pre-determined amount of air was more effective than a non-adjustable device for achieving patent hemostasis, thereby reducing the incidence of acute radial artery...
This study evaluated whether the use of an adjustable device inflated with a pre-determined amount of air was more effective than a non-adjustable device for achieving patent hemostasis, thereby reducing the incidence of acute radial artery...
This study evaluated whether the...
02/26/2024
Journal of Invasive Cardiology
Original Contribution
Impact of Mitral Stenosis on Early and Late Outcomes of Transcatheter Aortic Valve Replacement for Aortic Stenosis: A Single-Center Analysis
02/26/2024

Yoshiyuki Yamashita, MD, PhD1; Serge Sicouri, MD1; Aleksander Dokollari, MD, PhD2; Mikiko Senzai, MD1; Roberto Rodriguez, MD3; Eric M. Gnall, MD4; Paul M. Coady, MD4; Harish Jarrett, MD5;Sandra V. Abramson, MD5; Katie M. Hawthorne, MD5; Scott M. Goldman, MD3; William A. Gray, MD4; Basel Ramlawi, MD1, 3

Yoshiyuki Yamashita, MD, PhD1; Serge ...
This study aims to evaluate both early and late outcomes in patients undergoing transcatheter aortic valve replacement according to the severity of concomitant mitral stenosis.
This study aims to evaluate both early and late outcomes in patients undergoing transcatheter aortic valve replacement according to the severity of concomitant mitral stenosis.
This study aims to evaluate both...
02/26/2024
Journal of Invasive Cardiology
Review
Burnout in Cardiology: A Narrative Review
02/26/2024

Michaella Alexandrou, MD1; Bahadir Simsek, MD1; Athanasios Rempakos, MD1; Spyridon Kostantinis, MD1; Judit Karacsonyi, MD, PhD1; Bavana V. Rangan, BDS, MPH1; Olga C. Mastrodemos, BA1; Salman S. Allana, MD1; Sunil V. Rao, MD2; Mark Linzer, MD3; Mohaned Egred, MD4; Anastasios Milkas, MD5; Yader Sandoval, MD1; M. Nicholas Burke, MD1; Emmanouil S. Brilakis, MD, PhD1

Michaella Alexandrou, MD1; Bahadir Si...
This review summarizes recent publications on burnout in cardiology, discusses the contributing factors and implications of burnout on physicians’ health and patient safety, and explores possible interventions.
This review summarizes recent publications on burnout in cardiology, discusses the contributing factors and implications of burnout on physicians’ health and patient safety, and explores possible interventions.
This review summarizes recent...
02/26/2024
Journal of Invasive Cardiology

Feature

Clinical Images
Tough Balloon With a Vulnerable Shaft: An Unexpected Device Failure
02/29/2024

Konstantinos C. Theodoropoulos, MD, MSc, PhD; Konstantinos Tsakiridis, MD; Polychronis Vazakidis, MD; George Kassimis, MD, PhD; Antonios Ziakas, MD, PhD

Konstantinos C. Theodoropoulos, MD, M...
A 73-year-old man, with a previous long drug-eluting stent from the mid-portion of the left main stem artery to proximal left anterior descending artery (LAD), underwent elective coronary angiogram due to worsening anginal symptoms and an...
A 73-year-old man, with a previous long drug-eluting stent from the mid-portion of the left main stem artery to proximal left anterior descending artery (LAD), underwent elective coronary angiogram due to worsening anginal symptoms and an...
A 73-year-old man, with a...
02/29/2024
Journal of Invasive Cardiology
Clinical Images
Ambulatory Trans-femoral Intra-aortic Balloon Pump
02/27/2024

Faris G. Araj, MD1; Haley Ashton, PT, DPT2; Binod Bista, OTR2; Brooke Wilson, DPT, CCS2; Meredith Smith, PT, DPT2

Faris G. Araj, MD1; Haley Ashton, PT,...
A 53-year-old man with inotrope-dependent advanced heart failure was admitted with acute decompensation and underwent urgent listing for heart transplant.
A 53-year-old man with inotrope-dependent advanced heart failure was admitted with acute decompensation and underwent urgent listing for heart transplant.
A 53-year-old man with...
02/27/2024
Journal of Invasive Cardiology
Clinical Images
Spontaneous Multivessel Coronary Artery Spasm: A Case Report
02/27/2024

Cheng-jian Wang, MSc1,2; Qing-cheng Wang, MD3; Ying Du, MSc1,2; Peng-fei Sun, MSc1,2; Ya-hui Ding, MD2

Cheng-jian Wang, MSc1,2; Qing-cheng W...
A 60-year-old male presented to the emergency department of our hospital with persistent dull pain in the lower and middle sternum with generalized sweating after a heated argument with another person, and his symptoms did not resolve after 3...
A 60-year-old male presented to the emergency department of our hospital with persistent dull pain in the lower and middle sternum with generalized sweating after a heated argument with another person, and his symptoms did not resolve after 3...
A 60-year-old male presented to...
02/27/2024
Journal of Invasive Cardiology
Clinical Images
Acute Myocardial Infarction Associated With Multiple Giant Coronary Artery Aneurysms: A Management Dilemma
02/27/2024

Shu Xian Loh, MRCP1; Md Azizul Hasan Khandaker FCPS, MRCP, MD1; Nicholas Jenkins, MRCP2; Philip Gonzales, MRCP1; Bilal Bawamia, MBBS, MD, MRCP1

Shu Xian Loh, MRCP1; Md Azizul Hasan ...
A 77-year-old man presented with an acute inferior ST-segment elevation myocardial infarction.
A 77-year-old man presented with an acute inferior ST-segment elevation myocardial infarction.
A 77-year-old man presented with...
02/27/2024
Journal of Invasive Cardiology
Clinical Images
A Guidewire-Free Approach for Percutaneous Closure of Left Ventricular Pseudoaneurysm
02/26/2024

Tahir Bezgin, MD1; Aziz Inan Celik, MD1; Nart Zafer Baytugan, MD1; Suleyman Karakoyun, MD2,3; Metin Cagdas, MD1

Tahir Bezgin, MD1; Aziz Inan Celik, M...
A 78-year-old male patient with a history of coronary artery disease, heart failure with mildly reduced ejection fraction, diabetes mellitus, and transient ischemic attack presented to the emergency department with complaints of dyspnea...
A 78-year-old male patient with a history of coronary artery disease, heart failure with mildly reduced ejection fraction, diabetes mellitus, and transient ischemic attack presented to the emergency department with complaints of dyspnea...
A 78-year-old male patient with...
02/26/2024
Journal of Invasive Cardiology
Brief Communication
Validation of the J-Channel Score for Retrograde Channel Crossing in the PROGRESS-CTO Registry
02/26/2024

Deniz Mutlu, MD1; Athanasios Rempakos, MD1; Michaella Alexandrou, MD1; Ahmed Al-Ogaili, MD1; Jaikirshan J. Khatri, MD2; Khaldoon Alaswad, MD3; Sevket Gorgulu, MD4; Yader Sandoval, MD1; M. Nicholas Burke, MD1; Emmanouil S. Brilakis, MD, PhD1

Deniz Mutlu, MD1; Athanasios Rempakos...
The authors examined the performance of the J-Channel score in patients who underwent retrograde chronic total occlusion percutaneous coronary intervention at 31 centers between 2013-2023 as part of the Prospective Global Registry for the...
The authors examined the performance of the J-Channel score in patients who underwent retrograde chronic total occlusion percutaneous coronary intervention at 31 centers between 2013-2023 as part of the Prospective Global Registry for the...
The authors examined the...
02/26/2024
Journal of Invasive Cardiology

Column

Letter to the Editor
Bedside Popliteal Vein Cannulation for Simultaneous Plasmapheresis and Renal Replacement Therapy in the Prone Position
02/26/2024

Naveen Balakrishnan, MD1; Hadi Beaini, MD2; Spencer Carter, MD3; Faris G. Araj, MD2

Naveen Balakrishnan, MD1; Hadi Beaini...
The COVID-19 pandemic has imposed challenging scenarios, necessitating a “thinking outside the box” approach for patients with profound respiratory failure requiring mechanical ventilation in the prone position.
The COVID-19 pandemic has imposed challenging scenarios, necessitating a “thinking outside the box” approach for patients with profound respiratory failure requiring mechanical ventilation in the prone position.
The COVID-19 pandemic has...
02/26/2024
Journal of Invasive Cardiology

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

News

Transcatheter Heart Valves
LANDMARK Trial: Meril Announces Successful Primary Outcomes of Next-Gen Myval THV Series in Major RCT
05/17/2024

Meril Life Sciences News

Meril Life Sciences News
Professor Serruys, Chairman & study director of the LANDMARK trial, said, "Myval THV series are novel next-gen THV devices; non-inferior to the Sapien and Evolut THV series. Myval THV series have a unique size matrix incorporating...
Professor Serruys, Chairman & study director of the LANDMARK trial, said, "Myval THV series are novel next-gen THV devices; non-inferior to the Sapien and Evolut THV series. Myval THV series have a unique size matrix incorporating...
Professor Serruys, Chairman &...
05/17/2024
Cath Lab Digest
Heart Failure
Implicity Earns FDA Clearance for New Heart Failure Prediction Algorithm
05/17/2024

Implicity News

Implicity News
SignalHF is unique in that the manufacturer-agnostic solution can be used to analyze data collected from a variety of CIEDs, including implantable cardiac defibrillators (ICD), pacemakers (PM) and cardiac resynchronization therapy devices...
SignalHF is unique in that the manufacturer-agnostic solution can be used to analyze data collected from a variety of CIEDs, including implantable cardiac defibrillators (ICD), pacemakers (PM) and cardiac resynchronization therapy devices...
SignalHF is unique in that the...
05/17/2024
Cath Lab Digest
Coronary Implants
DESyne BDS Plus RCT: Late-Breaking 12-Month Data Demonstrate Significant Improvement in Safety and Effectiveness of World’s First Site-Specific Antithrombotic Therapeutic Compared to DES
05/16/2024

Elixir Medical News

Elixir Medical News
DESyne BDS Plus has a bioresorbable coating containing three drugs: two anticoagulants (rivaroxaban and argatroban) and an antiproliferative mTOR inhibitor (sirolimus) designed for delivery of site-specific antithrombotic therapeutic.
DESyne BDS Plus has a bioresorbable coating containing three drugs: two anticoagulants (rivaroxaban and argatroban) and an antiproliferative mTOR inhibitor (sirolimus) designed for delivery of site-specific antithrombotic therapeutic.
DESyne BDS Plus has a...
05/16/2024
Cath Lab Digest
Intravascular Lithotripsy
Primary Outcomes From PINNACLE I Clinical Trial Establish Safety and Effectiveness of Elixir Medical’s Hertz Contact IVL in Moderate to Severe Calcified Coronary Artery Lesions
05/16/2024

Elixir Medical News

Elixir Medical News
The novel LithiX Hertz Contact Intravascular Lithotripsy (IVL) system is designed to address challenges associated with the percutaneous treatment of nodular, concentric, and eccentric moderate to severe calcified lesions resistant to optimal...
The novel LithiX Hertz Contact Intravascular Lithotripsy (IVL) system is designed to address challenges associated with the percutaneous treatment of nodular, concentric, and eccentric moderate to severe calcified lesions resistant to optimal...
The novel LithiX Hertz Contact...
05/16/2024
Cath Lab Digest
Bioadaptors
BIOADAPTOR RCT Data Demonstrate Significant Clinical Advantage of Elixir Medical’s DynamX Bioadaptor Over Standard of Care Drug-Eluting Stent at Two Years
05/16/2024

Elixir Medical News

Elixir Medical News
Elixir Medical announced two-year results from the BIOADAPTOR randomized controlled (1:1) trial, comparing the DynamX® Coronary Bioadaptor System to standard of care Resolute Onyx™ Drug-Eluting Stent from 34 centers in Japan, Europe, and New...
Elixir Medical announced two-year results from the BIOADAPTOR randomized controlled (1:1) trial, comparing the DynamX® Coronary Bioadaptor System to standard of care Resolute Onyx™ Drug-Eluting Stent from 34 centers in Japan, Europe, and New...
Elixir Medical announced...
05/16/2024
Cath Lab Digest
Intravascular Lithotripsy
FastWave Medical Granted Fifth Utility Patent Reflecting Continuous Expansion of IVL IP Portfolio
05/16/2024

FastWave Medical News

FastWave Medical News
The newly granted patent bolsters the innovative design of FastWave's next-generation IVL platform, aimed at overcoming challenges associated with treating calcified arteries in patients with occlusive vascular disease.
The newly granted patent bolsters the innovative design of FastWave's next-generation IVL platform, aimed at overcoming challenges associated with treating calcified arteries in patients with occlusive vascular disease.
The newly granted patent...
05/16/2024
Cath Lab Digest
IMAGING
One in Three People Die Due to Atherosclerosis: A New Initiative, REACT, Aims to Find New Ways to Prevent It
05/16/2024

Centro Nacional de Investigaciones Cardiovasculares Carlos III (F.S.P.) News

Centro Nacional de Investigaciones Ca...
“REACT will develop – at scale - methods to directly visualize the disease (atherosclerosis),” says Dr. Borja Ibáñez, Scientific Director of CNIC, cardiologist at Fundación Jiménez Díaz hospital, and leader of the Spanish part of the study.
“REACT will develop – at scale - methods to directly visualize the disease (atherosclerosis),” says Dr. Borja Ibáñez, Scientific Director of CNIC, cardiologist at Fundación Jiménez Díaz hospital, and leader of the Spanish part of the study.
“REACT will develop – at scale -...
05/16/2024
Cath Lab Digest
hypertension
Patient “Chronotype” Could Impact Best Time to Take Blood Pressure Medication
05/16/2024

University of Dundee News

University of Dundee News
Scientists observed that so-called “morning larks” (earlier chronotypes) who took their prescribed blood pressure medication in the morning were less likely to experience a heart attack than those who were “misaligned” and took it in the...
Scientists observed that so-called “morning larks” (earlier chronotypes) who took their prescribed blood pressure medication in the morning were less likely to experience a heart attack than those who were “misaligned” and took it in the...
Scientists observed that...
05/16/2024
Cath Lab Digest
Extreme exercise
JAMA: Exercise Does Not Accelerate Artery Plaque Buildup More Often Seen in Fitness Enthusiasts
05/16/2024

UT Southwestern Medical Center News

UT Southwestern Medical Center News ...
The study, which analyzed more than 8,700 participants from 1998-2019, provides important insight on whether people whose heart scans detect higher calcium should modify their exercise regimen to slow the plaque buildup in arteries.
The study, which analyzed more than 8,700 participants from 1998-2019, provides important insight on whether people whose heart scans detect higher calcium should modify their exercise regimen to slow the plaque buildup in arteries.
The study, which analyzed more...
05/16/2024
Cath Lab Digest
Pregnancy
Infertility Treatment Doubles Risk of Postpartum Heart Disease
05/15/2024

Rutgers University News

Rutgers University News
“We have been involved in a series of studies over the past few years that have found serious risks of heart disease and stroke to various high-risk patient populations within those initial 30 days after delivery – risks that could be...
“We have been involved in a series of studies over the past few years that have found serious risks of heart disease and stroke to various high-risk patient populations within those initial 30 days after delivery – risks that could be...
“We have been involved in a...
05/15/2024
Cath Lab Digest

Advertisement

Advertisement

Advertisement

Transcatheter Heart Valves
LANDMARK Trial: Meril Announces Successful Primary Outcomes of Next-Gen Myval THV Series in Major RCT
05/17/2024

Meril Life Sciences News

Meril Life Sciences News
Professor Serruys, Chairman & study director of the LANDMARK trial, said, "Myval THV series are novel next-gen THV devices; non-inferior to the Sapien and Evolut THV series. Myval THV series have a unique size matrix incorporating...
Professor Serruys, Chairman & study director of the LANDMARK trial, said, "Myval THV series are novel next-gen THV devices; non-inferior to the Sapien and Evolut THV series. Myval THV series have a unique size matrix incorporating...
Professor Serruys, Chairman &...
05/17/2024
Cath Lab Digest
Heart Failure
Implicity Earns FDA Clearance for New Heart Failure Prediction Algorithm
05/17/2024

Implicity News

Implicity News
SignalHF is unique in that the manufacturer-agnostic solution can be used to analyze data collected from a variety of CIEDs, including implantable cardiac defibrillators (ICD), pacemakers (PM) and cardiac resynchronization therapy devices...
SignalHF is unique in that the manufacturer-agnostic solution can be used to analyze data collected from a variety of CIEDs, including implantable cardiac defibrillators (ICD), pacemakers (PM) and cardiac resynchronization therapy devices...
SignalHF is unique in that the...
05/17/2024
Cath Lab Digest
Coronary Implants
DESyne BDS Plus RCT: Late-Breaking 12-Month Data Demonstrate Significant Improvement in Safety and Effectiveness of World’s First Site-Specific Antithrombotic Therapeutic Compared to DES
05/16/2024

Elixir Medical News

Elixir Medical News
DESyne BDS Plus has a bioresorbable coating containing three drugs: two anticoagulants (rivaroxaban and argatroban) and an antiproliferative mTOR inhibitor (sirolimus) designed for delivery of site-specific antithrombotic therapeutic.
DESyne BDS Plus has a bioresorbable coating containing three drugs: two anticoagulants (rivaroxaban and argatroban) and an antiproliferative mTOR inhibitor (sirolimus) designed for delivery of site-specific antithrombotic therapeutic.
DESyne BDS Plus has a...
05/16/2024
Cath Lab Digest
Intravascular Lithotripsy
Primary Outcomes From PINNACLE I Clinical Trial Establish Safety and Effectiveness of Elixir Medical’s Hertz Contact IVL in Moderate to Severe Calcified Coronary Artery Lesions
05/16/2024

Elixir Medical News

Elixir Medical News
The novel LithiX Hertz Contact Intravascular Lithotripsy (IVL) system is designed to address challenges associated with the percutaneous treatment of nodular, concentric, and eccentric moderate to severe calcified lesions resistant to optimal...
The novel LithiX Hertz Contact Intravascular Lithotripsy (IVL) system is designed to address challenges associated with the percutaneous treatment of nodular, concentric, and eccentric moderate to severe calcified lesions resistant to optimal...
The novel LithiX Hertz Contact...
05/16/2024
Cath Lab Digest
Bioadaptors
BIOADAPTOR RCT Data Demonstrate Significant Clinical Advantage of Elixir Medical’s DynamX Bioadaptor Over Standard of Care Drug-Eluting Stent at Two Years
05/16/2024

Elixir Medical News

Elixir Medical News
Elixir Medical announced two-year results from the BIOADAPTOR randomized controlled (1:1) trial, comparing the DynamX® Coronary Bioadaptor System to standard of care Resolute Onyx™ Drug-Eluting Stent from 34 centers in Japan, Europe, and New...
Elixir Medical announced two-year results from the BIOADAPTOR randomized controlled (1:1) trial, comparing the DynamX® Coronary Bioadaptor System to standard of care Resolute Onyx™ Drug-Eluting Stent from 34 centers in Japan, Europe, and New...
Elixir Medical announced...
05/16/2024
Cath Lab Digest
Intravascular Lithotripsy
FastWave Medical Granted Fifth Utility Patent Reflecting Continuous Expansion of IVL IP Portfolio
05/16/2024

FastWave Medical News

FastWave Medical News
The newly granted patent bolsters the innovative design of FastWave's next-generation IVL platform, aimed at overcoming challenges associated with treating calcified arteries in patients with occlusive vascular disease.
The newly granted patent bolsters the innovative design of FastWave's next-generation IVL platform, aimed at overcoming challenges associated with treating calcified arteries in patients with occlusive vascular disease.
The newly granted patent...
05/16/2024
Cath Lab Digest
IMAGING
One in Three People Die Due to Atherosclerosis: A New Initiative, REACT, Aims to Find New Ways to Prevent It
05/16/2024

Centro Nacional de Investigaciones Cardiovasculares Carlos III (F.S.P.) News

Centro Nacional de Investigaciones Ca...
“REACT will develop – at scale - methods to directly visualize the disease (atherosclerosis),” says Dr. Borja Ibáñez, Scientific Director of CNIC, cardiologist at Fundación Jiménez Díaz hospital, and leader of the Spanish part of the study.
“REACT will develop – at scale - methods to directly visualize the disease (atherosclerosis),” says Dr. Borja Ibáñez, Scientific Director of CNIC, cardiologist at Fundación Jiménez Díaz hospital, and leader of the Spanish part of the study.
“REACT will develop – at scale -...
05/16/2024
Cath Lab Digest
hypertension
Patient “Chronotype” Could Impact Best Time to Take Blood Pressure Medication
05/16/2024

University of Dundee News

University of Dundee News
Scientists observed that so-called “morning larks” (earlier chronotypes) who took their prescribed blood pressure medication in the morning were less likely to experience a heart attack than those who were “misaligned” and took it in the...
Scientists observed that so-called “morning larks” (earlier chronotypes) who took their prescribed blood pressure medication in the morning were less likely to experience a heart attack than those who were “misaligned” and took it in the...
Scientists observed that...
05/16/2024
Cath Lab Digest
Extreme exercise
JAMA: Exercise Does Not Accelerate Artery Plaque Buildup More Often Seen in Fitness Enthusiasts
05/16/2024

UT Southwestern Medical Center News

UT Southwestern Medical Center News ...
The study, which analyzed more than 8,700 participants from 1998-2019, provides important insight on whether people whose heart scans detect higher calcium should modify their exercise regimen to slow the plaque buildup in arteries.
The study, which analyzed more than 8,700 participants from 1998-2019, provides important insight on whether people whose heart scans detect higher calcium should modify their exercise regimen to slow the plaque buildup in arteries.
The study, which analyzed more...
05/16/2024
Cath Lab Digest
Pregnancy
Infertility Treatment Doubles Risk of Postpartum Heart Disease
05/15/2024

Rutgers University News

Rutgers University News
“We have been involved in a series of studies over the past few years that have found serious risks of heart disease and stroke to various high-risk patient populations within those initial 30 days after delivery – risks that could be...
“We have been involved in a series of studies over the past few years that have found serious risks of heart disease and stroke to various high-risk patient populations within those initial 30 days after delivery – risks that could be...
“We have been involved in a...
05/15/2024
Cath Lab Digest

May 2024 Volume 36 Issue 5

View Issue Archive
Editorial Correspondence

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use

Advertisement

Advertisement